2012 CTRC-AACR San Antonio Breast Cancer Symposium to focus on new treatments, diagnosis and prevention

November 29, 2012

SAN ANTONIO -- The 2012 CTRC-AACR San Antonio Breast Cancer Symposium will be held at the Henry B. Gonzales Convention Center in San Antonio, Texas, Dec. 4-8. Now in its 35th year, the symposium will feature new research focusing on emerging treatments in hard-to-treat populations, such as patients with triple-negative breast cancer, and new knowledge on biologic targets and prevention.

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the AACR and Baylor College of Medicine will jointly present the symposium. The driving force behind this collaboration is the shared mission of the organizations to advance progress in breast cancer research.

To help guide coverage for the news media, the AACR Communications and Public Relations Department will operate a full-service press room in Room 217A-C of the convention center. In addition, three press conferences will be held in Room 217D. Reporters who cannot attend in person can participate using the following information:The first press conference will be on Wednesday, Dec. 5 at 7:30 a.m. CT, and will be hosted by Peter Ravdin, M.D., Ph.D., director of the Breast Health Clinic at the CTRC. It will focus on the following research:On Thursday, Dec. 6 at 7:30 a.m. CT, Carlos L. Arteaga, M.D., associate director for clinical research and director of the Breast Cancer Program at Vanderbilt Ingram Cancer Center, will host a press conference featuring the following research:On Friday, Dec. 7 at 7:30 a.m. CT, C. Kent Osborne, M.D., director of the Lester and Sue Smith Breast Cancer Center at Baylor College of Medicine, will host a press conference featuring the following research:The 2012 CTRC-AACR San Antonio Breast Cancer Symposium will also present awards:
-end-
The mission of the 2012 CTRC-AACR San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for patients with breast cancer. The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research (AACR) and Baylor College of Medicine are joint sponsors of the San Antonio Breast Cancer Symposium. This collaboration utilizes the clinical strengths of the CTRC and Baylor and the AACR's scientific prestige in basic, translational and clinical cancer research to expedite the delivery of the latest scientific advances to the clinic. For more information about the symposium, please visit www.sabcs.org.

American Association for Cancer Research

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.